{"id":5126,"date":"2011-09-06T15:55:29","date_gmt":"2011-09-06T15:55:29","guid":{"rendered":"http:\/\/crashtext.org\/misc\/5126.htm\/"},"modified":"2018-11-10T17:46:28","modified_gmt":"2018-11-10T22:46:28","slug":"ischemic-stroke","status":"publish","type":"post","link":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/","title":{"rendered":"Ischemic Stroke (CVA)"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><a href=\"\/wp-content\/images\/part1\/stroke.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part1\/stroke_small.jpg\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>Lacunar\/small vessel strokes-usually eithe risolated sensory or isolated motor<\/p>\n<p>Cortical\/large vessel=alterations of cosciousness, thinking, language<\/p>\n<p>Ant=leg, Arm\/face=MCA, Homonymous hemianopsia=PCA<\/p>\n<p>Must, must do sensory exam inthese patients, often times they will not complain fo sensory c\/o<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"NNT\"><\/span>NNT<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><a href=\"\/wp-content\/images\/part3\/nnt%20for%20stroke%20studies.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part3\/nnt%20for%20stroke%20studies_small.jpg\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>from Michael Liao<\/p>\n<p>NINDSNNT 6 (42.7% vs 26.5%)NNH 17 (6.4% vs 0.6%)ECASSIIINNT 14 (52.4% vs 45.2%)NNH 47 (2.4% vs 0.2%)&#8230;. 23 (7.9% vs 3.5% with NINDS definitions)NNT is based on mRS &lt;= 1 at 3 moNNH is based on symptomatic ICHI use all the NINDS data as it appears they skewed both part 1 andpart 2 (artificially(?)) to have approx half of the patients in the0-90min time windows. I find NINDS a bit trickier to piece back together than ECASS3.<\/p>\n<p>&#8212;<\/p>\n<p>&nbsp;<\/p>\n<p>Expansion of TPA window to 4.5 hours by AHA (Stroke 2009;40:)<\/p>\n<p>ECASS III<\/p>\n<p><strong>Table 1 ECASS III Exclusion Criteria<\/strong><\/p>\n<ul>\n<li>Age &lt; 18 or &gt; 80 years<\/li>\n<li>Onset of stroke &gt; 4.5 hours before drug administration or symptom onset unknown<\/li>\n<li>Stroke symptoms present &lt; 30 minutes or significantly improving before treatment<\/li>\n<li>Intracranial hemorrhage<\/li>\n<li>Severe stroke as defined by NIHSS &gt; 25 or imaging (CT or MRI) displaying &gt; 1\/3 of middle cerebral artery territory involved<\/li>\n<li>Seizure at the onset of stroke<\/li>\n<li>Stroke or serious head trauma within the previous 3-months<\/li>\n<li>Combination of previous stroke and diabetes mellitus<\/li>\n<li>Heparin within the preceding 48 hours with PTT above normal limit<\/li>\n<li>Platelet count &lt; 100,000 mm3<\/li>\n<li>Systolic blood pressure &gt; 185 mm Hg or diastolic &gt; 110 mm Hg or aggressive treatment (intravenous medication) to reduce blood pressure to these limits<\/li>\n<li>Glucose &lt; 50 mg\/dL or &gt; 400 mg\/dL<\/li>\n<li>Symptoms suggestive of subarachnoid hemorrhage even if CT normal<\/li>\n<li>Oral anticoagulation therapy<\/li>\n<li>Major surgery or severe trauma within 3-months<\/li>\n<li>Other major disorders with an increased risk of bleeding<\/li>\n<\/ul>\n<p><strong>The Evidence <\/strong><a href=\"http:\/\/pmid.us\/18815396\">Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, N Engl J Med 2008; 359: 1317-1329.<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>t-PA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Placebo\u00a0\u00a0\u00a0 NNT\u00a0\u00a0\u00a0 NNHGood Recovery at 90 Days\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong>\u00a0\u00a0\u00a0 52.4%\u00a0\u00a0\u00a0\u00a0 45.2%\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 14\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 N\/A<strong> Symptomatic ICH\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong>2.4%\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0.3%\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 N\/A\u00a0\u00a0\u00a0\u00a0 47<strong>Death\u00a0\u00a0\u00a0\u00a0<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 7.7%\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 8.4%\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 N\/A\u00a0\u00a0\u00a0\u00a0 N\/A<\/p>\n<p>Tenecteplase vs. Alteplase-New inclusion criteria, manufacturer supported, (N Engl J Med 2012;366:1099-107.)<\/p>\n<p>&nbsp;<\/p>\n<p><strong> Acute Stroke with NIHSS Score of 0<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Physicians rely on the National Institutes of Health Stroke Scale (NIHSS) to evaluate patients with suspected acute stroke and to make decisions about acute treatment. The NIHSS correlates with infarct size, clinical severity, and long-term outcome. It is important to recognize, however, that ischemic stroke may cause symptoms that are not captured by the NIHSS scale.<\/p>\n<p>The NIHSS scale is highly weighted toward deficits caused by anterior circulation strokes, whereas deficits caused by posterior circulation strokes receive fewer points (1-3).\u00a0 Within the anterior circulation, the scale underestimates the degree of right versus left hemisphere injury (1,4). It is possible that some patients with persistent symptoms on arrival to ED and an NIHSS score of 0 still have an infarct (1).<\/p>\n<p>In a recent study, stroke patients with an NIHSS score of 0 most commonly presented with nausea, vomiting, and headache, all of which are associated with posterior circulation ischemia (1). Midline lesions of the cerebellum cause truncal ataxia, which is not part of the NIHSS.\u00a0 In addition, decreased visual acuity, Horner&#8217;s syndrome, and memory impairments are neurologic deficits not captured by the NIHSS.\u00a0 Subtle limb weakness (4\/5) in an upper motor neuron pattern (extensors of the arms or flexors of the legs) may not be observed on the motor component of the NIHSS.<\/p>\n<p>These data reinforce that the NIHSS cannot replace history and a thorough neurologic exam to diagnose acute stroke and that the NIHSS alone cannot be used to rule out a stroke in patients with acute persistent symptoms.<\/p>\n<p><em> References:<\/em><\/p>\n<p>(1) Martin-Schild S, et al.\u00a0\u00a0 Zero on the NIHSS Does Not Equal the Absence of Stroke <em> Ann Emerg Med<\/em> 2010 Sep 8. [Epub ahead of print]<\/p>\n<p>(2) Libman RB, et al. Differences between anterior and posterior circulation stroke in TOAST <em> Cerebrovasc Dis<\/em> 2001;11:311\u0096316.<\/p>\n<p>(3) Sato S, et al. Baseline NIH stroke scale score predicting outcome in anterior and posterior circulation strokes <em> Neurology<\/em> 2008;70:2371\u00962377.<\/p>\n<p>(4) Fink JN, et al. Is the association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere ischemic stroke? <em> Stroke<\/em> 2002;33:954\u0096958.<\/p>\n<p>(Source Unknown Sorry!!!!!)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"2009_AHA_Stroke_Imaging_Recs\"><\/span>2009 AHA Stroke Imaging Recs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Acute Stroke, Neuroimaging, and Thrombolysis<\/strong><\/p>\n<ul>\n<li>MRI is at least equal in efficacy to CT for detection of ICH in the hyperacute stroke patient, and both appear to have very high sensitivity and specificity. MRI is superior to CT for demonstration of subacute and chronic hemorrhage and hemorrhagic transformation of an acute ischemic stroke.<\/li>\n<\/ul>\n<ul>\n<li>MR-DWI (diffusion weighted imaging MR) is far superior to unenhanced CT and routine MRI in the detection of acute ischemia, with very high sensitivity and specificity. For a patient within 3 hours of symptom onset, MRI can be used if it does not unduly delay the timely administration of IV tPA since a more definitive diagnosis will be obtained with MR-DWI and it is far more effective than CT for excluding some mimics of acute cerebral ischemia.<\/li>\n<\/ul>\n<ul>\n<li>For patients beyond 3 hours from onset of symptoms, either MR-DWI or CTA should be performed, especially if mechanical thrombectomy or intra-arterial thrombolytic therapy is contemplated.<\/li>\n<\/ul>\n<ul>\n<li>Frank hypointensity on CT, particularly if it involves more than one third of an MCA territory, is a strong contraindication to treatment with thrombolysis. Early signs of infarct on CT, regardless of their extent, are not a contraindication to treatment.<\/li>\n<\/ul>\n<ul>\n<li>Gradient-echo MR can detect microhemorrhage, both old and new, better than CT, indicating the presence of amyloid angiopathy, hypertension, small vascular malformations, and other vascular diseases. The presence of a small number of these microhemorrhages (&lt; 5) does not contraindicate intravenous thrombolysis.<\/li>\n<\/ul>\n<p><em>Reference: <\/em>Latchaw RE,et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association <em> Stroke<\/em> 2009;40(11):3646-78.<\/p>\n<p>&nbsp;<\/p>\n<p>_____<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Advanced_Stroke_Imaging_References\"><\/span>Advanced Stroke Imaging References<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><a href=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/CTP-future-CVA-imaging-ann-Neurol-2009.pdf\">CTP future CVA imaging ann Neurol 2009<\/a><\/li>\n<li><a href=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/CTP-CT-in-AIS-neurorad-2010.pdf\">CTP CT in AIS neurorad 2010<\/a><\/li>\n<li><a href=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/CTP-AIS-TPA-imaging-review-2007.pdf\">CTP AIS TPA imaging review 2007<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Early_CT_Signs_of_Ischemic_Stroke\"><\/span>Early CT Signs of Ischemic Stroke<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>from emedhome<\/p>\n<p>The NINDS Study found a 31% sensitivity for early signs of ischemic stroke on noncontrast CT within 3 hours of symptom onset. The rate of detection increased to 82% at 6 hours (1).<\/p>\n<p>Early signs of cerebral ischemia on CT:<\/p>\n<ul>\n<li>Hypoattenuation\u00a0of brain tissue &#8211; with ischemia, cytotoxic edema develops resulting in increased brain water content. There is a\u00a0loss of gray-white differentiation\u00a0because of the increase in the relative water concentration within the ischemic tissues.<\/li>\n<li>With edema, swelling of the gyri produces\u00a0sulcal effacement, which may lead to ventricular compression.<\/li>\n<li>Hyperdense MCA sign\u00a0&#8211; a result of thrombus or embolus in the MCA.<a href=\"\/wp-content\/images\/part6\/hyperdense%20mca%20ct%20from%20EMJ.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part6\/hyperdense%20mca%20ct%20from%20EMJ_small.jpg\" alt=\"Hyperdense MCA on Right\" \/><\/a><\/li>\n<li>Obscuration of the lentiform nucleus\u00a0(also called blurred basal ganglia) is seen in MCA infarction and is one of the most frequently seen signs.<\/li>\n<li>Insular Ribbon sign\u00a0refers to hypodensity and swelling of the insular cortex (the center of the cerebral cortex deep between the temporal lobe and the frontal lobe).<\/li>\n<\/ul>\n<p>The sooner these signs become evident, the more profound is the degree of ischemia (1,2). Typically, at 6-12 hours sufficient edema is recruited into the stroke area to produce significant regional hypodensity on CT; a large hypodense area present within 3 hours of reported symptom onset should prompt careful review regarding the time of stroke symptom onset.<\/p>\n<p>There is controversy as to whether early signs of infarct on CT are a contraindication to thrombolysis. The presence of CT evidence of infarction early in presentation has been associated with poor outcome and increased propensity for hemorrhagic transformation after thrombolytics in some studies (3,4).\u00a0 In the NINDS trial, there was no interaction between early infarction signs and tPA treatment for any clinical outcomes. Currently early signs of ischemia on CT are not generally considered to be a contraindication to use of tPA. \u00a0However, &#8220;frank hypointensity&#8221; on CT, particularly if it involves more than one third of an MCA territory, is a strong contraindication to treatment (1).<\/p>\n<p>References:<\/p>\n<p>(1 ) Latchaw et al.\u00a0 Recommendations for imaging acute ischemic stroke:\u00a0 A scientific statement from the American Heart Association \u00a0Stroke\u00a02009;40:3646-78.<\/p>\n<p>(2) Patel SC, et al. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke\u00a0JAMA. 2001;286: 2830\u00962838.<\/p>\n<p>(3) von Kummer R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy\u00a0Radiology1997;205(2):327-33.<\/p>\n<p>(4) Dzialowski I, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II\u00a0Stroke\u00a02006;37(4):973-8.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>80-85% of strokes<\/p>\n<p>majority are thrombotic vs. embolic (Mitral Stenosis, MI, A-Fib)<\/p>\n<p>Hallmark of stroke is sudden onset of focal neurological derangement in a vascular area<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Differential\"><\/span>Differential<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Hemorrhage<\/strong> <strong>Migraine<\/strong> <strong>Hyperglycemia<\/strong> <strong>Carotid Dissection<\/strong> <strong>Todd&#8217;s Paralysis<\/strong> <strong>Bell&#8217;s<\/strong> <strong>Encephalitis\/Abscess<\/strong> <strong>Temporal Arteritis<\/strong> <strong>Hypoglycemia<\/strong> <strong>Hyponatremia<\/strong> <strong>Hypertensive Encephalopathy<\/strong> <strong>Air Embolism<\/strong> <strong>Multiple Sclerosis<\/strong> <strong>Dementia<\/strong><\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Common_Major_Stroke_Syndromes\"><\/span>Common Major Stroke Syndromes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Anterior Circulation<\/strong><\/p>\n<p>Frontoparietal Lobes<\/p>\n<p>Anterior Aspect of Temporal Lobes<\/p>\n<p>Optic Nerve and Retina<\/p>\n<p>Deep Gray Matter Structures<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Posterior Circulation<\/strong><\/p>\n<p>Medial Aspect of Temporal Lobes<\/p>\n<p>Visual Occipital Cortex<\/p>\n<p>Thalamus<\/p>\n<p>Brainstem<\/p>\n<p>Upper Spinal Cord<\/p>\n<p>Cerebellum<\/p>\n<p>Auditory and Vestibular Aspects of the Ear<\/p>\n<p>&nbsp;<\/p>\n<h4>Anterior cerebral artery<\/h4>\n<p>Paralysis mainly of opposite leg and mild arm involvement<\/p>\n<p>Sensory deficits paralleling paralysis<\/p>\n<p>Altered mentation, confusion, judgment, and impaired insight<\/p>\n<p>Gait apraxia (clumsiness)<\/p>\n<p>Bowel and bladder incontinence<\/p>\n<h4>Middle cerebral artery<\/h4>\n<p>Paralysis of opposite side of body; arm and face worse than leg<\/p>\n<p>Sensory deficits paralleling paralysis<\/p>\n<p>Blindness in half of visual field (hemianopsia)<\/p>\n<p>Aphasia (if dominant hemisphere involved, usually left)<\/p>\n<p>Hemineglect (If non-dominant hemisphere, usually right)<\/p>\n<p>Inability to recognize known objects (agnosia)<\/p>\n<p>If Gaze preference, patients look towards the lesion<\/p>\n<figure id=\"attachment_10879\" aria-describedby=\"caption-attachment-10879\" style=\"width: 600px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-10879 size-medium\" src=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU-600x448.jpg\" alt=\"\" width=\"600\" height=\"448\" srcset=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU-600x448.jpg 600w, https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU-768x573.jpg 768w, https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU-1024x765.jpg 1024w, https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU.jpg 1500w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/a><figcaption id=\"caption-attachment-10879\" class=\"wp-caption-text\">from Taming the SRU<\/figcaption><\/figure>\n<h4><\/h4>\n<h4>Posterior cerebral artery<\/h4>\n<p>Blindness in one half of visual field (hemianopsia)<\/p>\n<p>Third nerve paralysis<\/p>\n<p>Lack of visual recognition (visual agnosia)<\/p>\n<p>Altered mental status with impaired memory<\/p>\n<p>Cortical blindness<\/p>\n<h4>Brainstem\/Cerebellum<\/h4>\n<p>Crossed Signs-face one side, body the other<\/p>\n<p>Hemiparesis or quadriparesis (or worse yet locked in syndrome)<\/p>\n<p>Sensory loss, hemi or all 4 extremities<\/p>\n<p>Diplopia<\/p>\n<p>Dysconjugate Gaze<\/p>\n<p>Nystagmus<\/p>\n<p>Dysarthria\/Dysphagia<\/p>\n<p>Vertigo<\/p>\n<p>Decreased LOC or syncope<\/p>\n<p>Ataxia<\/p>\n<p>Vomitting<\/p>\n<p><a href=\"\/wp-content\/images\/part1\/case63_fig1.gif\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part1\/case63_fig1_small.gif\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>Patients presenting with pontine infarction may describe a preceding transient pain radiating from the unilateral eye to the nose, following which they developed numbness or ataxic hemiparesis on the side contralateral to the pain.4 The \u0093beauty parlor syndrome\u0094 has been described in elderly patrons receiving shampoo treatments. Mechanical impingement by neck rotation and hyperextension decreases vertebral artery flow and produces hypoperfusion at the atlanto-occipital-distal vertebral artery junction. Patients may present with vertigo and ataxia.5<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Evaluation\"><\/span>Evaluation<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Stroke notification<\/p>\n<p>Check Glucose<\/p>\n<p>Consider Aortic Dissection or if neck pain in the absence of trauma, consider arterial dissection of neck vessels<\/p>\n<p>Obtain a BP in both arms<\/p>\n<p>NIH Stroke Scale (<a href=\"http:\/\/www.ferne.org\">FERNE<\/a>) , but remember it leaves out some CN, gait, and nystagmus<\/p>\n<p>EKG<\/p>\n<p>Draw Labs-CBC, PT\/PTT, Lytes, C-XR, Consider ABG, C-Spine, LFTs<\/p>\n<p>Get a stat CT Minus Head<\/p>\n<p>&nbsp;<\/p>\n<p>multimodal MRI including gradient echo is at least as and probably more sensitive for bleeds than CT (J Neuro Neurosurg Psych 2001 Apr;70 suppl 1:I7-11)<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"\/wp-content\/images\/part1\/emr030804_table3.gif\" alt=\"\" \/><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Management\"><\/span>Management<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<h4>BP<\/h4>\n<p>One study showed cardene\/labetalol lowering of BP before TPA may be assoc. with higher adverse events, but it may just be that patients with HTN do worse (Arch Neurol 2008;65:1174)<\/p>\n<p>Keep MAP&lt;130<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>Positioning<\/h4>\n<p>Hob flat may increase CPP (Neurology 2005;64:1354)<\/p>\n<h4><\/h4>\n<h4>Cerebral Edema<\/h4>\n<p>Elevate head of bed to 30\u00ba<\/p>\n<p>Hyperventilation or Mannitol only if acute deterioration<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4>Seizures<\/h4>\n<p>Only to prevent recurrent seizures<\/p>\n<h4>Anticoagulation<\/h4>\n<p>ASA well proven (huge Chinese study)<\/p>\n<p>No harm if you give it in hemorrhagic stroke, but still not advised (Stroke, 2000;31:1240-1249)<\/p>\n<p>No benefit to other anticoagulants unless concerns over pt with current A.Fib (Stroke 33:856, 2002)<\/p>\n<h4>TPA<\/h4>\n<p>lytics up to 4.5 hours (NEJM 2008;359(13):1317)<\/p>\n<p>&nbsp;<\/p>\n<p>Must be read by neuroradiologist (Neurologists, general radiologists, and certainly ER docs are not qualified)<\/p>\n<p>BP must be less than 185\/110<\/p>\n<p>&nbsp;<\/p>\n<p>The NINDS trial was divided into two parts; in both parts, patients were randomized to receive tPA, 0.9 mg\/kg, or placebo within three hours after onset of stroke symptoms. Patients in the treatment arm were given 0.9 mg\/kg tPA (maximum dose, 90 mg) in a 10% bolus followed by a constant infusion of the remaining 90% over 60 minutes. The first part enrolled 291 patients and measured whether they had improvement in their NIHSS score of four points or more over baseline or resolution of deficits within 24 hours of onset of stroke. In this portion of the trial, there was no statistical difference between the tPA group and the placebo recipients (P = 0.21). However, in post hoc analysis, the authors point out that the median NIHSS scores were two points lower in the 0- to 90-minute range and four points lower in the 90- to 180-minute range when the tPA group was compared with placebo (P value not provided). The second part enrolled 333 patients and assessed clinical outcomes at three months. Patients who received tPA were at least 30% more likely to have minimal or no disability based on four measures of neurologic disability (NIHSS, modified Rankin, Glasgow outcome scale, and Barthel Index). The primary hypothesis in part two was tested with a global statistic to simultaneously test for effect in all four outcome measures. Symptomatic intracerebral hemorrhage occurred in 6.4% of tPA recipients but only 0.6% of placebo recipients (P &lt; 0.001). Mortality at three months was 17% in the tPA group and 21% in the placebo group (P = 0.30). A number-needed-to-treat analysis of the NINDS trial indicates that for every eight acute stroke patients treated, one will benefit. One patient in 17 will suffer an intracranial hemorrhage, and one in 40 will die. These numbers may be helpful in explaining risks and benefits to patients who are eligible for thrombolytic treatment.<\/p>\n<p>&nbsp;<\/p>\n<p>Meta-analysis of current thrombolytic for stroke data Symptomatic ICH 6.2% Absolute Risk Increase Fatal ICH 2.5% Absolute Risk Increase (Stroke. 2003 Jun;34(6):1437-42.)<\/p>\n<p>&nbsp;<\/p>\n<p>The major risk of t-PA is symptomatic intracerebral hemorrhage, which occurred in 6.4 percent of patients who received t-PA, as compared with 0.6 percent of patients who received placebo.1 These figures represent an absolute difference in the risk of symptomatic intracerebral hemorrhage of 6 percent. Seventy-five percent of the patients with a symptomatic intracerebral hemorrhage were dead at three months. Yet despite the risk of intracerebral hemorrhage, the mortality at three months was insignificantly lower in patients treated with t-PA (17 percent) than in placebo-treated patients (21 percent). Two reasons may underlie the similar mortality of t-PA\u00adtreated and placebo-treated patients despite a higher risk of symptomatic intracerebral hemorrhage among patients treated with t-PA. First, most patients who had an intracerebral hemorrhage had large strokes and were likely to do poorly regardless of the presence of intracerebral hemorrhage within the damaged brain. Secondly, t-PA probably makes some &#8220;big&#8221; strokes much smaller. The patients with small strokes are less likely to die. Patients treated with t-PA who have very large strokes (very severe neurologic deficits, meaning an NIH stroke scale score greater than 20) and who already have evidence of a large acute ischemic stroke on baseline CT have an increased risk of symptomatic intracerebral hemorrhage. 17 However, patients in these two subgroups who receive t-PA are more likely to return to normal than patients who are treated with placebo. The decision to use t-PA in these patients should be made only after frank discussion of the potential risks and benefits with both the patient and the family. Figure 1 adapted from Marx J. Classification system for stroke patients. Proceedings of the National Symposium on Rapid Identification and Treatment of Acute Stroke, December 13, 1996. Washington, D.C.: National Institute of Neurological Disorders and Stroke (NINDS), November 1997.<\/p>\n<p><strong>Contraindications to TPA<\/strong><\/p>\n<p><a href=\"\/wp-content\/images\/part1\/emr030804_table4.gif\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part1\/emr030804_table4_small.gif\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Get TEE, eval ekg for A-Fib.\u00a0 Carotid dopplers.<\/p>\n<p>ASA or plavix<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.stroke-site.org\/guidelines\/tpa_guidelines.html\">Site for NINDS Group Guidelines for TPA<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>editorial on why it has not been adopted more widely (Lancet 2006;5:722)<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"\/wp-content\/images\/part2\/ninds%20results.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part2\/ninds%20results_small.jpg\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"ECASS-III\"><\/span>ECASS-III<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><a href=\"\/wp-content\/images\/part2\/ecassiii.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part2\/ecassiii_small.jpg\" alt=\"\" \/><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Endovascular_Treatments\"><\/span>Endovascular Treatments<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>From Resus.me by Cliff Reid:<\/strong><\/p>\n<div>\n<div>\n<p>Two randomised controlled trials have been published which compare endovascular stroke treatments with intravenous tPA. Both the American Interventional Management of Stroke (IMS) III trial (1) and the Italian SYNTHESIS Expansion trial (2) had <a href=\"http:\/\/en.wikipedia.org\/wiki\/Modified_Rankin_Scale\" target=\"_blank\" rel=\"noopener\">Modified Rankin Scores<\/a> as their primary endpoint. No significant differences in this outcome or in mortality or intracranial haemorrhage rates were found in either trial, and IMS III was terminated early due to futility.<\/p>\n<p>A third trial, from North America, called MR RESCUE, randomised patients within 8 hours after the onset of large vessel, anterior-circulation strokes to undergo mechanical embolectomy or receive standard care(3). No clinical outcome differences were demonstrated.<\/p>\n<p>An accompanying editorial (4) draws the following conclusion:<\/p>\n<blockquote><p><em>\u201cThe IMS III and SYNTHESIS Expansion studies show that intravenous thrombolysis should continue to be the first-line treatment for patients with acute ischemic stroke within 4.5 hours after stroke onset, even if imaging shows an occluded major intracranial artery. Beyond 4.5 hours, the MR RESCUE trial does not provide data supporting the use of endovascular treatment in patients with an ischemic penumbra of any size.\u201d<\/em><\/p><\/blockquote>\n<p>Many might argue that showing endovascular treatment is equivalent to thrombolysis just means endovascular treatment doesn\u2019t work, because a significant proportion of the emergency medicine community views this as the correct interpretation of a <a href=\"http:\/\/www.smartem.org\/podcasts\/smart-thrombolytics-acute-stroke\" target=\"_blank\" rel=\"noopener\">thorough analysis of the stroke thrombolysis literature<\/a>.<\/p>\n<p>1. <strong>Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke<\/strong><br \/>\n<a href=\"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1214300\" target=\"_blank\" rel=\"noopener\">NEJM Feb 8, 2013 Full Text Link<\/a><\/p>\n<p>2. <strong>Endovascular Treatment for Acute Ischemic Stroke<\/strong><br \/>\n<a href=\"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1213701\" target=\"_blank\" rel=\"noopener\">NEJM Feb 8, 2013 Full Text Link<\/a><\/p>\n<p>3. <strong>A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke<\/strong><br \/>\n<a href=\"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1212793\" target=\"_blank\" rel=\"noopener\">NEJM Feb 8, 2013 Full Text Link<\/a><\/p>\n<p>4.<strong>Endovascular Treatment for Acute Ischemic Stroke \u2014 Still Unproven<\/strong><br \/>\n<a href=\"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMe1215730\" target=\"_blank\" rel=\"noopener\">NEJM Feb 8, 2013 Full Text Link<\/a><\/p>\n<\/div>\n<\/div>\n<p>Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke\u00a0\u00a0 J.P. Broderick and Others | N Engl J Med 2013;368:893-903 |\u00a0 No benefit when IA was added to IV tPA<\/p>\n<h4>Cerebellar Stroke<\/h4>\n<p>Neurosurgery consult<\/p>\n<h4>Misc.<\/h4>\n<p>Elevated CK-MB after stroke are not necessarily indicative of AMI, need elevated Troponin to properly eval. (Stroke 33:286 2002)<\/p>\n<p>&nbsp;<\/p>\n<p>Giving ASA even to hemorrhagic stroke did not cause additional mortality or increased bleeds (Stroke 2000; 31:1240-9)<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Old_Stroke_Patients\"><\/span>Old Stroke Patients<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>may still be safe to lyse patients &gt; 80 y\/o (BMJ 2010;341:c6046)<\/p>\n<p>Andy has editorial as well (ACEP News Feb 2011)<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Young_Stroke_Patients\"><\/span>Young Stroke Patients<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<p><strong>Strokes in Younger Patients (EMEDhome)<\/strong><\/p>\n<p>When evaluating a younger patient in the Emergency Department with a stroke, keep in mind the following:<\/p>\n<ul>\n<li>Cardiac causes including Right-to-Left shunts from a patent foramen ovale (PFO) or occult atrial septal defect (ASD).<\/li>\n<li>Cocaine and amphetamine use<\/li>\n<li>Atrial myxoma<\/li>\n<li>Cervical artery dissections.\u00a0\u00a0 Approximately 20% of strokes in the young are caused by carotid artery and vertebral artery dissections in the neck, compared to 2.5% in older patients.<\/li>\n<\/ul>\n<p>As transesophageal echocardiography (TEE) is considered the most sensitive method to date to detect PFO (1), think to suggest a TEE as part of the evaluation.<\/p>\n<p>&#8220;In the absence of other causative conditions, an ASD or PFO may be presumed to be the underlying cause of cerebrovascular thromboembolism. The search for these defects will be more cost-effective in younger stroke patients who, unlike older patients, rarely have the cardiovascular conditions associated with advanced age that commonly cause strokes in the elderly&#8221; (2).<em>References: <\/em>(1) Horton SC, Bunch TJ. Patent foramen ovale and stroke\u00a0 <em>Mayo Clin Proc<\/em> 2004;79(1): 79-88<em>. <\/em> (2)\u00a0 Jaber WA, et al. Suspect an atrial septal defect if a young patient has a stroke <em>Cleveland Clin J Med<\/em>\u00a0 2001; 68: 954-956. (3) Cabanes L, et al.\u00a0 Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. <em>Stroke<\/em> 1993; 24:1865-1873. (4)\u00a0 Jones J, Geninatti M. Cardiology\u00a0 <em>Emerg Med Clin North Am<\/em> 1997;15(2):341-63.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"\/wp-content\/images\/part3\/vasc%20wu%20young%20tia.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part3\/vasc%20wu%20young%20tia_small.jpg\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>from emedhome.com<\/p>\n<p>Think Endocarditis in Young Patients With Apparent Stroke Neurologic complications occur in approximately one-third of cases of infective endocarditis and typically present as a stroke syndrome.<\/p>\n<p>Valvular vegetations can embolize to the brain and causes cerebral infarction, usually in a branch of the middle cerebral artery, causing contralateral motor or sensory symptoms. However, infarction can occur anywhere in the cerebral circulation, producing a myriad of possible neurologic symptoms. Infectious vegetations can embolize to branch points in the cerebral vascular tree, causing the formation of mycotic aneurysms. A mycotic aneurysm is an aneurysm that results from an infectious process that involves the arterial wall. These are noted in up to 2% of patients with infective endocarditis, causing symptoms due to mass effect, vascular leakage, or sudden rupture. This can lead to a broad spectrum of clinical presentations ranging from subarachnoid hemorrhage to meningitis to coma.<\/p>\n<p>Infective endocarditis is therefore an important consideration when a young person who has no risk factors for premature cerebrovascular disease who presents to the ED with stroke symptoms, particularly when the patient has risk factors for the development of infective endocarditis, such as IV drug use or valvular heart disease, or presents with a fever. References:\u00a0 (1) Mattu A, Goyal D.\u00a0Emergency Medicine: Avoiding the Pitfalls and Improving the Outcomes\u00a0\u00c2\u00a9 Blackwell, 2007\u00a0 (2) Crawford MH, Durack DT. Clinical presentation of infective endocarditis\u00a0Cardiol Clin\u00a02003;21: 159-66.\u00a0 (3) Tunkel AR, Kaye D. Neurologic complications of infective endocarditis\u00a0Neurol Clin\u00a01993;11: 419-40.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Exam\"><\/span>Exam<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>(Jama 2005;293(19):2391)<\/p>\n<p>LR of the absence of facial paresis, arm drift, and abnormal speech is 0.39<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Oxfordshire Classification of Subtypes of Cerebral Infarction*<\/strong><\/p>\n<p>Totalanterior circulation infarction syndrome (TACS)<\/p>\n<dl>\n<dd>\n<dl>\n<dd>A combinationof new higher cerebral dysfunction (ie, dysphasia, dyscalculia, visuospatial disorder); homonymous visual field defect; and ipsilateral motor and\/or sensory deficit of at least 2 areasof the face, arm, and leg.<\/dd>\n<\/dl>\n<\/dd>\n<\/dl>\n<p>Partial anterior circulation infarction syndrome (PACS)<\/p>\n<p>&nbsp;<\/p>\n<dl>\n<dd>\n<dl>\n<dd>Only 2 of the 3 components of theTACS syndrome are present, with higher cerebral dysfunction alone, or with a motor\/sensory deficit more restricted thanthose classified as LACS (ie, confined to 1 limb or to faceand hand, but not to the whole arm).<\/dd>\n<\/dl>\n<\/dd>\n<\/dl>\n<p>Lacunar infarctionsyndrome (LACS)<\/p>\n<dl>\n<dd>\n<dl>\n<dd>Pure motor stroke, pure sensory stroke, sensori-motorstroke, or ataxic hemiparesis.<\/dd>\n<\/dl>\n<\/dd>\n<\/dl>\n<p>Posterior circulation infarction syndrome (POCS)<\/p>\n<dl>\n<dd>\n<dl>\n<dd>Any of the following: ipsilateral cranial nervepalsy with contralateral motor and\/or sensory deficit; bilateralmotor and\/or sensory deficit; disorder of conjugate eye movement; cerebellar dysfunction without ipsilateral long-tract deficit(ie, ataxic hemiparesis); or isolated homonymous visual fielddefect.<\/dd>\n<\/dl>\n<\/dd>\n<\/dl>\n<p>*Based on data from Bamford et al.<a href=\"#REF-JRC50003-54\">54<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sub-Arachnoid_Hemorrhage_SAH\"><\/span>Sub-Arachnoid Hemorrhage (SAH)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><\/h3>\n<h2><span class=\"ez-toc-section\" id=\"Posterior_Circulation_Stroke\"><\/span><em>Posterior Circulation Stroke<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"\/wp-content\/pdf\/Posterior%20circulation%20cereb...pdf\">posterior circ stroke<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><em>Neurologists have described acute confusional states and acute agitated delirium with several sites of infarction [<a href=\"#bib4\">4<\/a>, <a href=\"#bib5\">5<\/a> and <a href=\"#bib6\">6<\/a>]. Some have been bilateral, others on the right (non-dominant) or the left (dominant) specifically. Restlessness, agitation and disorientation are common with posterior artery infarctions. Forced crying out, cursing and unintelligible speech often have been reported in these cases, as they were in our patient [<a href=\"#bib2\">2<\/a>]. Hypertension and generalized slowing on EEG are described in some patients, whereas others have normal CT scans for some time before changes of density can be identified [<a href=\"#bib2\">2<\/a>]. The course of delirium can last several weeks with varying outcomes. Older age, comorbidity, and extent of the infarction have significant impact. Our patient had a history that included diabetes mellitus, hypertension, adenocarcinoma, and psychiatric disorders, all of which could have produced some of the initial symptoms. It is unlikely that her fever was due to medications, because she had been taking them for weeks, or that it was due to infection, because an organism could not be cultured and the white blood cell count was persistently normal. The maximum outside temperature on that day was 76\u00b0C. <\/em><\/p>\n<p><em>The Amitriptyline and Nortriptyline levels were less than 10 ng\/ml. It is known that acute strokes can cause elevated temperature, agitation and hypothermia. Although total CK level was not obtained, it is unlikely that agitation caused the fever, as it persisted even after agitation resolved with sedation. The ultimate cause of her fever was puzzling, but the most likely etiology was the stroke. Whether or not the antibiotics prescribed at the onset eradicated an undetected infection was never resolved. The confirmed diagnosis of left posterior cerebral artery infarction certainly could have explained the majority of her signs and symptoms as well as the course. <\/em><\/p>\n<p><em>It is quite important to consider this diagnosis early as it carries a high mortality, particularly in the elderly [<a href=\"#bib2\">2<\/a>]. Rapid intervention with TPA is increasingly initiated to spare neuronal damage when it can be administered shortly after an event. It would not have been given to this patient 11 h post infarction. Because initial CT scans may not be diagnostic, an MRI or MRA is more definitive. Plan for workup depends on initial clinical evaluation, although in most hospitals the first imaging study would be a CT scan. A CT scan can exclude unexpected large lesions or the presence of bleeding but other investigations are necessary to identify the stenotic or occluded artery. Abnormal diffusion weighted imaging (DWI) is a very sensitive and specific identifier of ischemic stroke in patients presenting within 6 h of stroke. Although DWI can detect areas of ischemia within 15\u009630 min of onset after only 3 s of imaging, its availability is limited. CT scans are more available, easily obtained and cheaper than MRIs or DWIs, so they are usually ordered first. But when non-diagnostic and at the earliest suspicion of ischemic stroke, the alternatives should be considered. Once the delirium clears, post-stroke depression should be reassessed. Untreated depression has a negative impact on both rehabilitation and long-term prognosis, and a premorbid history for depression significantly increases the risk for recurrence. Post-stroke depression is a well-known phenomenon and consistent with our patient&#8217;s symptoms [<a href=\"#bib7\">7<\/a>]. When the anterior limbic system is disconnected from the destroyed posterior, the amygdala and anterior hippocampus can also induce confusion, fever, anger and amnesia. The infarct will also disrupt connections between the temporal neocortex and the limbic system, making it extremely difficult to use language-encoded memories. As time progresses to allow for collateral circulation, the symptoms may resolve if the infarction is not so large that it causes devastating destruction. <\/em><\/p>\n<p><em>In conclusion, infarction of the posterior cerebral artery, whether unilateral or bilateral, may present first as delirium without many focal findings. When suspected, an MRI should be immediately obtained to help clarify a diagnosis. Intervention with TPA in all non-hemorrhagic strokes remains controversial but patients treated within 90 min definitely have improved outcomes. Early identification of the patients who may benefit from this approach is essential [<a href=\"#bib8\">8<\/a>]. The affected limbic structures can produce early psychiatric symptoms involving delirium and altered affect and the later development of post-stroke depression. <\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>ATLANTIS trial:\u00a0 Mild to moderate strokes 79% completely recover at 90 days vs. 56% for placebo.\u00a0 In moderate to severe, 33% TPA vs. 5% placebo.\u00a0 22% change of intracranial hemorrhage.\u00a0 All symptomatic hemorrhages were fatal. (Stroke 2002, 33:493-496)<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>ANTIPLATELET DRUG DISCONTINUATION IS A RISK FACTOR FOR ISCHEMIC STROKESibon, I., et al, Neurology 62:1187, April 2004<\/p>\n<p><strong>BACKGROUND:<\/strong> Prophylaxis with antiplatelet drugs is effective for the secondary prevention of cardio- and cerebrovascular disease. Only limited information is available concerning the occurrence of ischemic stroke in the setting of discontinuation of such treatment.<\/p>\n<p><strong>METHODS:<\/strong> These French authors interviewed 320 patients (or surrogates) hospitalized for a transient ischemic attack (TIA) or stroke, regarding their use of an anti- platelet drug (almost always aspirin), and any changes in that treatment, in the month before hospitalization.<\/p>\n<p><strong>RESULTS:<\/strong> Of the minority (31, 9.7%) with a hemorrhagic stroke, none had discontinued an antiplatelet drug during the previous month, while six were being anticoagulated. Of 289 patients with an ischemic infarction, antiplatelet drug therapy was discontinued during the month before the episode in 13\/103 who had been receiving it. The interval between discontinuation of anticoagulation and the occurrence of stroke was always 6-10 days, which is consistent with the timing of aspirin&#8217;s effect on platelets. In seven of the 13 cases, discontinuation of treatment was ordered by a physician prior to surgery, while in six it occurred due to &#8220;negligence&#8221; or based on the belief that treatment was not clinically relevant.<\/p>\n<p><strong>CONCLUSIONS:<\/strong> There may be an increased risk of stroke fairly shortly after discontinuation of antiplatelet drug prophylaxis. 8 references (igor.sibon@chu-bordeaux.fr)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>NINDS study:<\/strong> <\/em> <em>inclusion criteria\u0097ischemic stroke with clearly defined time of onset; measurable deficit on National Institutes of Health (NIH) stroke scale; no evidence of intracranial hemorrhage on computed tomography (CT) of brain; <\/em> <em>treatment\u0097t- PA 0.9 mg\/kg for maximum of 90 mg (10% given as bolus, 90% as constant infusion over 60 min [smaller than cardiac dose]); patient not to receive anticoagulants or antiplatelet drugs for 24 hr after treatment; strict protocol for blood pressure monitoring and control; <\/em> <em>exclusion criteria\u0097prior stroke or head trauma within 3 mo; major surgery in previous 14 days; history of intracranial hemorrhage; hypertension; suspected transient ischemic attack (TIA); <\/em> <em>hypothesis\u0097consistent and persuasive difference between t-PA and placebo in patients who recover with minimal or no deficit 3 mo after treatment; <\/em> <em>outcome\u0097t-PA group had higher percentage of favorable outcomes; no increase in severe disability or death resulting from administration of t-PA; however, \u0093you were ten times more likely to develop a symptomatic intracranial hemorrhage resulting from your stroke if you got t-PA than if you didn\u0092t\u0094; mortality from symptomatic intracranial hemorrhage 45% higher than mortality from disease process itself; t-PA patients 32% to 55% more likely to have complete recovery from stroke than placebo group (11%-13% more patients have complete recovery with t-PA than without it); must treat 8 to 9 patients to obtain one additional complete recovery; all patients with ischemic stroke benefited equally, regardless of size; these results held at 6 mo and 1 yr <\/em> <em><strong>Recommendations of Stroke Council of American Heart Association:<\/strong> published in 1996; t-PA should be given according to NINDS protocol by physicians with expertise in diagnosis of stroke and interpretation of CT; streptokinase should not be used; do not treat if CT signs suggest major infarct or treating facility cannot handle complications of intracranial hemorrhage (need neurosurgery backup plan); use caution in severe strokes (score &gt;22 on NIH stroke scale); obtain informed consent <\/em><\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>NIH stroke scale:<\/strong> fairly reliable and reproducible; primarily identifies lateralizing findings; evaluates 11 criteria; takes 5 to 8 min to perform; patient must have score &gt;4 but &lt;22 <\/em> <em><strong>CT criteria:<\/strong> must be done within 3 hr of symptom onset; parenchymal hypodensity indicates large stroke or long interval between time of stroke and patient\u0092s arrival; study showed correct interpretation of CT by emergency physicians in 66% of cases, 83% for neurologists and radiologists; only 70% of emergency physicians interpreted CT correctly 100% of time, 40% of neurologists and 50% of radiologists<\/em><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Comparison of MRI and CT for Detection of Acute Intracerebral Hemorrhage<\/strong><\/p>\n<p>JAMA. 2004;292:1823-1830. Results The study was stopped early, after 200 patients were enrolled, when it became apparent at the time of an unplanned interim analysis that MRI was detecting cases of hemorrhagic transformation not detected by CT. For the diagnosis of any hemorrhage, MRI was positive in 71 patients with CT positive in 29 (P&lt;.001). For the diagnosis of acute hemorrhage, MRI and CT were equivalent (96% concordance). Acute hemorrhage was diagnosed in 25 patients on both MRI and CT. In 4 other patients, acute hemorrhage was present on MRI but not on the corresponding CT\u0097each of these 4 cases was interpreted as hemorrhagic transformation of an ischemic infarct. In 3 patients, regions interpreted as acute hemorrhage on CT were interpreted as chronic hemorrhage on MRI. In 1 patient, subarachnoid hemorrhage was diagnosed on CT but not on MRI. In 49 patients, chronic hemorrhage, most often microbleeds, was visualized on MRI but not on CT.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Prognosis_and_Decision_Making_in_Severe_Stroke\"><\/span>Prognosis and Decision Making in Severe Stroke<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>JAMA 2005;294(6):725<\/p>\n<p>&nbsp;<\/p>\n<p>Our analysis suggests that EICs are prevalent within 3 hours of stroke onset and correlate with stroke severity. However, EICs are not independently associated with increased risk of adverse outcome after rt-PA treatment. Patients treated with rt-PA did better whether or not they had EICs, suggesting that EICs on CT scan are not critical to the decision to treat otherwise eligible patients with rt-PA within 3 hours of stroke onset. (JAMA. 2001 Dec 12;286(22):2830-8.)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Optimal stroke scale to lyse 10-20<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dizziness_and_Stroke\"><\/span>Dizziness and Stroke<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p>Stroke Among Patients With Dizziness, Vertigo, and Imbalance in the Emergency Department: A Population-Based Study Kerber KA, Brown DL, Lisabeth LD, et al. Stroke 2006;37:2484\u00967 Catherine Ambrose MDa aDenver Health Medical Center, Denver, Colorado Available online 30 March 2007. As part of the Brain Attack Surveillance in Corpus Christi (BASIC) project, this study sought to determine the percentage of stroke patients who presented to the Emergency Department (ED) with the complaints of dizziness, vertigo, or imbalance. This large population-based study examined all patients over the age of 44 years who presented to the ED or were directly admitted to the hospital between January 2000 and June 2003 with the previously mentioned isolated dizziness symptoms (DS) in Nueces County, Texas. The association of age, sex, race\/ethnicity, and isolated dizziness symptoms with stroke or transient ischemic attack (TIA) was then determined using multivariable logistic regression. A total of 1666 patients were included in the study, with 3.2% (53 of 1666) ultimately diagnosed with stroke\/TIA. Of those diagnosed, 23 presented with dizziness as the chief complaint, 18 with vertigo, 11 with imbalance, and 1 with more than one of the above symptoms. Isolated DS without additional neurological findings was a strong negative predictor of stroke\/TIA (odds ratio [OR] 0.05; 95% confidence interval [CI] 0.02\u00960.11), whereas male sex was associated with an increased association with stroke\/TIA (OR 2.5; 95% CI 1.4\u00964.4). Patients diagnosed with stroke\/TIA were also found to be significantly older (69.3 \u00b1 11.7 vs. 65.3 \u00b1 12.9, p = 0.02). No significant difference in race\/ethnicity was found between the stroke and non-stroke groups. When compared to dizziness, patients with imbalance were found to have an increased risk of stroke\/TIA (OR 3.7; 95% CI 1.3\u009610.7), whereas no increased risk was found between those with vertigo versus dizziness (OR 0.9; 95% CI 0.4\u00962.0). The authors acknowledge several limitations to this study, including lack of evaluation of the majority of study patients in the ED by a neurologist, lack of magnetic resonance imaging on most study patients leading to possible undiagnosed strokes, and lack of comparison of symptom onset, duration, aggravating\/alleviating factors, headache, and auditory symptoms between groups. The authors conclude that dizziness and vertigo are not associated with stroke\/TIA, whereas patients who present with imbalance, those with additional neurologic findings, male gender, and older age are at the highest risk for possible stroke\/TIA.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Rapid_approach_to_NIHSS\"><\/span>Rapid approach to NIHSS<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The NIHSS as formulated by the National Institute of Neurological Disorders and Stroke has been applied at our medical center as the SQS and is shown here with maximal deficit scores clustered into 3 groups having a total of 7points each (Fig. 1). The level of consciousness section to the NIHSS is grouped together in the frontal regions with an aggregate deficit score totaling 7 for deficits in alertness, ability to answer questions, and obey commands. A second cluster of 3 consisted of deficits in sensation, extinction, and language being clustered along the motor strip and temporal-parietal regions; the extinction category tests inattention with complete neglect scoring 2. In regards to sensory deficits, this can be tested as withdrawal to noxious stimuli, with a severe loss scoring 2 points. A third cluster was placed in the posterior regions and included the maximal visual deficit score of 3 for bilateral hemianopia, and the near to unintelligible deficit score of 2 for dysarthria was placed alongside the maximal limb ataxia score of 2 in the cerebellar region; although speech dysarthria can be a result of ischemic damage to the motor strip, an alternative possibility would be dysarthria of a cerebellar origin and for convenience is grouped here in the posterior fossa region. The maximal motor deficit score of 4 for each of 4 extremities is grouped together (green circle, Fig. 1). Miscellaneous items that are not part of the 322 groupings are separated by a line parallel to the catho-metal line: best gaze (forced deviation of the eyes scores 2 points) and facial palsy (complete facial palsy scores 3 points). 3. Discussion Although not yet formally tested under controlled conditions, the SQS diagram may accelerate the time factor in reaching an accurate score, but formal testing of this hypothesis is needed. Although the NIHSS attempts to comprehensively include all regions of the brain that could be affected by stroke, the weighting factors for each functional item might need reassessment. The current equal weighting for arms vs legs remains reasonable for now, because 1 study showed very good reliability for these items with the 15-item NIHSS [6]. However, the same study found the least reliable items to facial palsy and dysarthria with low intraclass correlation coefficients being less than 0.40, and advocated a modified 11-item version of the NIHSS. In summary, the presented SQS diagram shown in Fig. 1, or similar versions, may facilitate training of examiners to comprehend the overall structure of the NIHSS system. The SQS diagram is intended only to serve as a supplement and not a replacement for current methods of scoring. However, further testing of a single visual composite for the NIHSS as an ancillary tool is needed to determine its actual usefulness. (AJEM 2008;26:189)<\/p>\n<p><a href=\"\/wp-content\/images\/part1\/rapid%20NIH%20stroke%20score.jpg\"> <img decoding=\"async\" src=\"\/wp-content\/images\/part1\/rapid%20NIH%20stroke%20score_small.jpg\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>From EP Monthly:The year\u0092s top stroke advances <em>by Bobby Desai, MD<\/em><\/p>\n<p>]]&gt;\u00a0 <a href=\"\/wp-content\/images\/part1\/stroke-story-full.jpg\"> <img decoding=\"async\" title=\"\" src=\"\/wp-content\/images\/part1\/stroke-story-full_small.jpg\" alt=\"\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Lacunes_Lacunar_Infarcts\"><\/span>Lacunes &amp; Lacunar Infarcts<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The terms &#8220;lacune&#8221;, &#8220;lacunar infarct&#8221; and &#8220;lacunar stroke&#8221; are often used interchangeably, but they are not the same thing. Lacunes are 3 to 15 mm cerebrospinal fluid (CSF)-filled cavities in the basal ganglia or white matter, frequently observed coincidentally on imaging in older people, often not clearly associated with discrete neurological symptoms. &#8220;Lacunar stroke&#8221; describes a clinical stroke syndrome with the typical symptoms and signs referable to a small subcortical or brain stem lesion.<a href=\"http:\/\/eresources.library.mssm.edu:2227\/cgi\/content\/full\/39\/11\/2921#R1-523795\">1,2<\/a><a href=\"http:\/\/eresources.library.mssm.edu:2227\/cgi\/content\/full\/39\/11\/2921#R2-523795\"> &#8220;Lacunar infarct&#8221; should refer to a clinical stroke syndrome of lacunar type where the underlying lesion is an infarct on brain-imaging. On CT or MR T2-weighted and fluid-attenuated inversion recovery (FLAIR) imaging, an acute lacunar infarct can look just like a white matter lesion (WML), difficult to distinguish from an asymptomatic WML without diffusion-imaging to show a hyperintense signal (reduced on ADC), or a prior scan for comparison, especially in patients with WMLs. Some clinically evident acute lacunar infarcts may evolve with time into lacunes. These points are well-established.<\/a><\/p>\n<p><a href=\"http:\/\/eresources.library.mssm.edu:2227\/cgi\/content\/full\/39\/11\/2921#R2-523795\"> Less well-established is how many clinically evident lacunar infarcts ever cavitate to become &#8220;lacunes&#8221;. It seems generally assumed that all lacunes start life as an infarct, even if the patient did not notice anything, and therefore share the same risk factors, etiology, prognosis, pathogenesis, etc, as clinically evident lacunar infarcts.<\/a><a href=\"http:\/\/eresources.library.mssm.edu:2227\/cgi\/content\/full\/39\/11\/2921#R3-523795\">3\u00965<\/a> However, suppose only a proportion of lacunar stroke lesions, perhaps as few as a third, ever cavitate, with the majority that fail to cavitate retaining the appearance of a WML?6 Counting lacunes could result in spurious risk factor and etiologic associations for lacunar stroke. We should not assume that the pathogenesis of clinically evident lacunar stroke is the same as for clinically silent lacunes. Equally, similarity in appearance between WMLs and clinically evident acute lacunar infarct could imply similar causation. However, surely the fact that one has caused symptoms (lacunar stroke\/infarct) and the other not (WML\/lacune) is important in itself and should lead to their careful distinction in any research at least until we know more.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Hemicraniectomy_for_Malignant_Middle_Cerebral\"><\/span>Hemicraniectomy for Malignant Middle Cerebral<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>(<a href=\"\/wp-content\/pdf\/hemi%20for%20malignant%20MCA.pdf\">Review)<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Bleck:<\/p>\n<p>Perhaps I&#8217;m missing something, but as I read the case the patient was being treated with enoxaparin for secondary stroke prevention, presumably from a cardiac source since there would not be an indication to do so without a suspected cardiac source (excepting hospitals with the initials Must Give Heparin). \u00a0Many stroke neurologists would think that four days is too early to start anticoagulation because of the risk of hemorrhagic transformation. \u00a0This is an area of considerable controversy and little data, but a two week delay is commonly suggested. \u00a0I didn&#8217;t think this should go by without comment. \u00a0Now for a statement that may label me as a heretic, or an old guy to be ignored: I don&#8217;t think that the ease of use of enoxaparin justifies its use in this circumstance. \u00a0I only use unfractionated heparin by intravenous infusion without a bolus in this setting, and keep the PTT about 70 sec. \u00a0I don&#8217;t want a drug that may be too effective as an anticoagulant, or that I can&#8217;t reverse quickly. \u00a0And I would not send a patient home this quickly when starting anticoagulation. \u00a0Sorry, but this case demonstrates why.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Regarding treatments to stabilize the patient in order to get to the OR (or theatre for some of you, or operating department for people who object to the term room), this is one of the few circumstances in which more than modest hyperventilation is reasonable in the setting of ischemia; I might even hyperventilate more than David suggests, into the low to mid 20s for a brief period in order to get the patient to the OR. \u00a0Regarding the mannitol dose, no one knows this either, but I&#8217;d probably start with 1 gm\/kg on the theory that I want a high osmotic gradient and am not worried about rebound since the surgeon will make room for more swelling later. \u00a0In recent years I have used a lot more hypertonic saline, but I realize that the literature is mixed in this regard; this would be a circumstance in which 30 &#8211; 60 mL of 23.4% saline (sodium quadrate in pharmacy parlance) over 10 min might be best because it seems to work most quickly. \u00a0Coplin, what do you think as the holder of the IND for salt? \u00a0Raise the head of the bed and give neuromuscular junction blockade so there is no coughing (boy am I old-fashioned!); there&#8217;s no point in &#8216;following the exam&#8217; any longer. \u00a0Turn the FiO2 up to 1.0 try to get some oxygen in without having to raise the blood pressure pharmacologically, although it is probably going up pretty high on its own (and if it isn&#8217;t, or is falling, the game is probably over already). \u00a0Although there is no question that lowering core temperature lowers ICP, there isn&#8217;t time to do it here; the patient needs to be decompressed before any modality would work. \u00a0I suppose I might start running in some chilled saline, which we keep around for post-cardiac arrest hypothermia, on the way to the OR, but I wouldn&#8217;t do anything that would delay transit.<\/p>\n<p>&nbsp;<\/p>\n<p>I think the real question is whether to put in an external ventricular drain while the OR is being prepared. \u00a0There is likely to be obstructive hydrocephalus here, and one might lower the ICP substantially by relieving it. \u00a0The downside of this is the risk of upward herniation, which I have seen enough times to believe in and fear. \u00a0Some folks will put one in prophylactically and clamp it to have it in place already when the patient&#8217;s exam deteriorates. \u00a0If one does place an EVD, it shouldn&#8217;t be allowed to drain to atmospheric pressure; just take off a small amount of fluid. \u00a0Since in the emergent situation the fluid will initially gush out, this is another argument for placing it before the patient is trying to die.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Basilar_Artery_Occlusion_BAO\"><\/span>Basilar Artery Occlusion (BAO)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"\/wp-content\/pdf\/IV%20and%20IA%20TPA%20for%20BAO%20from%20med-pub.pdf\">From Google Knol<\/a><\/p>\n<p>Administered IV Tpa up to 24 hours (48 hours if fluctuating) (Stroke 2011;42:2175)<\/p>\n<h2><span class=\"ez-toc-section\" id=\"TPA_in_patients_on_Coumadin\"><\/span>TPA in patients on Coumadin<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>retrospective study showed increase post-tpa bleed rate even with INR &lt; 1.7 (Arch Neurol 2010;67(5):\u00a0 Prabhakaran)<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Critical_Review_Of_Decomp_Crani_for_Middle_Cerebral_Infarct\"><\/span>Critical Review Of Decomp Crani for Middle Cerebral Infarct<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Neurologist Issue: Volume 17(1),\u00a0January 2011,\u00a0p 63\u009666<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Posterior_circulation_stroke\"><\/span>Posterior circulation stroke<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ischaemic stroke of the posterior circulation may cause mild or non-specific acute symptoms that are not captured on the National Institutes of Health Stroke Scale (NIHSS). A study published in the Annals of Emergency Medicine (2011;<strong>57<\/strong>:42\u00965) reveaed that patients with an NIHSS score of 0 and a documented infarct on diffusion-weighted imaging, frequently presented with headache, vertigo, nausea and truncal ataxia. This highlights the need to be alert to this pattern of symptoms in order to investigate further and rule out a posterior circulation stroke.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neutrophilia\"><\/span>Neutrophilia<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Stroke. 2008 Feb;39(2):355-60. Epub 2007 Dec 27.Early neutrophilia is associated with volume of ischemic tissue in acute stroke.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Good_Care_for_Post-Stroke_is_most_Important_Factor\"><\/span>Good Care for Post-Stroke is most Important Factor<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>From EM Lit of Note Blog:<\/p>\n<p>This is a prospective interventional study in which acute stroke units<\/p>\n<p>in New South Wales Australia were randomized to either no protocolized<\/p>\n<p>intervention, or an intervention with nursing protocols named above. \u00a0At<\/p>\n<p>the end of the three-year intervention period, 42% of the control group<\/p>\n<p>had mRS 0 or 1 at 90 days, and 58% of the intervention group had mRS 0<\/p>\n<p>or 1 at 90 days. \u00a0There were small differences in the type of stroke,<\/p>\n<p>education level, and prior ability to work that probably favored the<\/p>\n<p>intervention group, but the differences at baseline were far smaller<\/p>\n<p>than the magnitude of the treatment effect. \u00a0In short, a basic nursing<\/p>\n<p>protocol intervention improved outcomes more than any other intervention<\/p>\n<p>for acute stroke.<\/p>\n<p>&#8220;Implementation of evidence-based treatment protocols to manage fever,<\/p>\n<p>hyperglycemia, and swallowing dysfunction in acute stroke (QASC): a<\/p>\n<p>cluster randomised controlled trial.&#8221;<\/p>\n<p>(Lancet, <a class=\"article-hdr-link\" href=\"http:\/\/www.thelancet.com\/journals\/lancet\/issue\/vol378no9804\/PIIS0140-6736%2811%29X6046-4\"> Volume 378, Issue 9804<\/a>, Pages 1699 &#8211; 1706, 12 November 2011)<\/p>\n<h2 id=\"article_link_container\"><span class=\"ez-toc-section\" id=\"Crossed_Leg_Sign\"><\/span>Crossed Leg Sign<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Leg crossing is an easily obtained clinical sign and is independent of additional technical<\/p>\n<p>examinations. Leg crossing within the first 15 days after severe stroke indicates a favorable<\/p>\n<p>outcome which includes less neurologic deficits, better independence in daily life, and lower rates<\/p>\n<p>of death. Neurology\u00ae 2011;77:1453\u20131456<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Warfarin_and_tPA\"><\/span>Warfarin and tPA<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>tPA may be ok if the patient is taking warfarin but is sub-therapeutic (<em>JAMA<\/em>. 2012;307(24):2600-2608)<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuroimaging_Negative_Stroke\"><\/span>Neuroimaging Negative Stroke<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Probably doesn&#8217;t exist as per <a href=\"http:\/\/www.emlitofnote.com\/2013\/04\/neuroimaging-negative-strokes-are-lie.html\">EM Lit of Note<\/a><\/p>\n<p>&#8220;Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator Is Rare and Unlikely to Indicate Averted Infarction&#8221;\u00a0<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23572476\" target=\"_blank\" rel=\"noopener\">http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23572476<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Speed_to_tPA\"><\/span>Speed to tPA<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke Jeffrey L. Saver, MD; Gregg C. Fonarow, MD; Eric E. Smith, MD, MPH; Mathew J. Reeves, PhD; Maria V. Grau-Sepulveda, MD, MPH; Wenqin Pan, PhD; DaiWai M. Olson, PhD; Adrian F. Hernandez, MD, MHS; Eric D. Peterson, MD, MPH; Lee H. Schwamm, MD JAMA. 2013;309(23):2480-2488. doi:10.1001\/jama.2013.6959.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Thalamic_Stroke_with_Normal_CTA\"><\/span>Thalamic Stroke with Normal CTA<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p class=\"expansion-article-title\">Artery of Percheron Infarction: Imaging Patterns and Clinical Spectrum<\/p>\n<p class=\"expansion-article-title\"><a href=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/F1.medium.gif\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-9688\" src=\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/F1.medium.gif\" alt=\"F1.medium\" width=\"440\" height=\"439\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dual_Anti-Platelet\"><\/span>Dual Anti-Platelet<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Assoc. with higher chance of hemorrhage (<b><\/b>Cucchiara B, Kasner SE<a href=\"http:\/\/www.imdb.com\/title\/tt0107290\/quotes\">,<\/a> Tanne D<a href=\"http:\/\/www.imdb.com\/title\/tt0107290\/quotes\">,<\/a> <a href=\"http:\/\/www.imdb.com\/title\/tt0107290\/quotes\">e<\/a>t a<a href=\"http:\/\/www.imdb.com\/title\/tt0107290\/quotes\">l<\/a>. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials<a href=\"http:\/\/www.imdb.com\/title\/tt0107290\/quotes\">.<\/a> Stroke. 2009 Sep;40(9):3067-72.)<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Isolated_hand_or_finger_palsy\"><\/span>Isolated hand or finger palsy<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>is<br \/>\nnot included in the NIH Stroke<br \/>\nScale, which is a weakness of the<br \/>\ntool because this type of palsy is<br \/>\na disabling clinical condition and<br \/>\ncould be an indicator of acute<br \/>\nischemic stroke. (West J Emerg<br \/>\nMed 2018;19[3]:524; http:\/\/bit.<br \/>\nly\/2OCzVW5.)<br \/>\nThe incidence of acute stroke<br \/>\nwith isolated hand paresis is not<br \/>\nknown, but it appears to constitute<br \/>\nfrom 0.83 percent to 1.5 percent of<br \/>\nall ischemic strokes. (Cerebrovasc<br \/>\nDis Extra 2013;3[1]:65; http:\/\/bit.ly\/<br \/>\n2OzrQ4k.) A paralysis of the hand<br \/>\nand fingers without sensory deficit is<br \/>\ndue to cortical infarction of the precentral<br \/>\ndial knob, a segment of the<br \/>\nprecentral gyrus that projects to<br \/>\nthe middle genu of the central sulcus.<br \/>\n(Neurology 2001;56[12]:1677.)<br \/>\nEmbolic mechanisms are more often<br \/>\nassociated with small cortical infarction<br \/>\nassociated with isolated hand<br \/>\nor finger palsy. (West J Emerg Med<br \/>\n2018;19[3]:524; http:\/\/bit.ly\/2OCzVW5;<br \/>\nNeurology 2001;56[12]:1677.)<br \/>\nClinicians must consider that patients<br \/>\nwith isolated hand palsy may<br \/>\nhave an alternative explanation, including<br \/>\na history of pain suggesting<br \/>\nvasculitis, waking from sleep with<br \/>\nthe deficit (compression), a fall<br \/>\n(trauma), and shoulder (neuralgic<br \/>\namyotrophy) or neck pain with radicular<br \/>\nsymptoms. The patient<br \/>\nshould be aggressively evaluated<br \/>\nand treated for acute ischemic<br \/>\nstroke if these findings are absent.<br \/>\n(West J Emerg Med 2018;19[<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Array<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[8,19],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ischemic Stroke (CVA) - Crashing Patient<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"CrashMaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"39 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/\",\"url\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/\",\"name\":\"Ischemic Stroke (CVA) - Crashing Patient\",\"isPartOf\":{\"@id\":\"https:\/\/crashingpatient.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU-600x448.jpg\",\"datePublished\":\"2011-09-06T15:55:29+00:00\",\"dateModified\":\"2018-11-10T22:46:28+00:00\",\"author\":{\"@id\":\"https:\/\/crashingpatient.com\/#\/schema\/person\/68373c312014141023ba30948675be1d\"},\"breadcrumb\":{\"@id\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#primaryimage\",\"url\":\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU.jpg\",\"contentUrl\":\"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU.jpg\",\"width\":1500,\"height\":1120},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/crashingpatient.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ischemic Stroke (CVA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/crashingpatient.com\/#website\",\"url\":\"https:\/\/crashingpatient.com\/\",\"name\":\"Crashing Patient\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/crashingpatient.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/crashingpatient.com\/#\/schema\/person\/68373c312014141023ba30948675be1d\",\"name\":\"CrashMaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crashingpatient.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/df72275d57de87ddb0cfafc82b66d544?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/df72275d57de87ddb0cfafc82b66d544?s=96&d=mm&r=g\",\"caption\":\"CrashMaster\"},\"url\":\"https:\/\/crashingpatient.com\/author\/emcrit\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ischemic Stroke (CVA) - Crashing Patient","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/","twitter_misc":{"Written by":"CrashMaster","Est. reading time":"39 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/","url":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/","name":"Ischemic Stroke (CVA) - Crashing Patient","isPartOf":{"@id":"https:\/\/crashingpatient.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#primaryimage"},"image":{"@id":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#primaryimage"},"thumbnailUrl":"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU-600x448.jpg","datePublished":"2011-09-06T15:55:29+00:00","dateModified":"2018-11-10T22:46:28+00:00","author":{"@id":"https:\/\/crashingpatient.com\/#\/schema\/person\/68373c312014141023ba30948675be1d"},"breadcrumb":{"@id":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#primaryimage","url":"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU.jpg","contentUrl":"https:\/\/crashingpatient.com\/wp-content\/uploads\/2011\/09\/MCAsyndromes-from-taming-the-SRU.jpg","width":1500,"height":1120},{"@type":"BreadcrumbList","@id":"https:\/\/crashingpatient.com\/medical-surgical\/ischemic-stroke.htm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/crashingpatient.com\/"},{"@type":"ListItem","position":2,"name":"Ischemic Stroke (CVA)"}]},{"@type":"WebSite","@id":"https:\/\/crashingpatient.com\/#website","url":"https:\/\/crashingpatient.com\/","name":"Crashing Patient","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/crashingpatient.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/crashingpatient.com\/#\/schema\/person\/68373c312014141023ba30948675be1d","name":"CrashMaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crashingpatient.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/df72275d57de87ddb0cfafc82b66d544?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df72275d57de87ddb0cfafc82b66d544?s=96&d=mm&r=g","caption":"CrashMaster"},"url":"https:\/\/crashingpatient.com\/author\/emcrit\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/posts\/5126"}],"collection":[{"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/comments?post=5126"}],"version-history":[{"count":0,"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/posts\/5126\/revisions"}],"wp:attachment":[{"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/media?parent=5126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/categories?post=5126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crashingpatient.com\/wp-json\/wp\/v2\/tags?post=5126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}